SCHEMBL6929151

SCHEMBL6929151

COc1ccccc1[S+](c1ccc(C)cc1)c1ccccc1OC.O=S(=O)([O-])c1ccc(C(F)(F)F)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.40
MEN1 O00255 1/20 0.39
ALOX15 P16050 1/20 0.39
MAPK1 P28482 1/20 0.39
KMT2A Q03164 1/20 0.39
ALDH1A1 P00352 1/20 0.39
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39
FFAR1 O14842 1/20 0.38
CDK1 P06493 1/20 0.38
CCNB1 P14635 1/20 0.38
CCNA2 P20248 1/20 0.38
CDK2 P24941 1/20 0.38
CDK7 P50613 1/20 0.38
CCNH P51946 1/20 0.38
CCNA1 P78396 1/20 0.38
FFAR4 Q5NUL3 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6850300 0.90 SMN1; SMN2 (0.39) GAAMEN1MAPK1KMT2ASMN1; SMN2
SCHEMBL6855470 0.87 HTR6 (0.42) GAAMEN1KMT2AALDH1A1SMN1; SMN2
Trifluoromethanesulfonic Acid SCHEMBL6855511 0.86 GPR3 (0.39) GAAMEN1KMT2AACHESMN1; SMN2
SCHEMBL7123641 0.84 SMN1; SMN2 (0.42) GAAMEN1KMT2ASMN1; SMN2
SCHEMBL5850133 0.83 KMT2A (0.40) GAAMEN1MAPK1KMT2AALDH1A1
SCHEMBL3136043 0.82 ALDH1A1 (0.46) MEN1MAPK1KMT2AALDH1A1BCHE
SCHEMBL3143572 0.82 ALDH1A1 (0.46) MEN1MAPK1KMT2AALDH1A1BCHE
SCHEMBL3132913 0.82 ALDH1A1 (0.46) MEN1MAPK1KMT2AALDH1A1BCHE
SCHEMBL3136569 0.82 ALDH1A1 (0.46) MEN1MAPK1KMT2AALDH1A1BCHE
SCHEMBL2902133 0.81 HSD11B1 (0.44) MAPK1ALDH1A1BCHEACHEFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030194634-A1 Novel anthracene derivative and radiation-sensitive resin composition JSR CORPORATION (JP) 2003-10-16 US disclosed
EP-1343048-A2 Anthracene derivative and radiation-sensitive resin composition JSR Corporation (JP) 2003-09-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030194634-A1 Novel anthracene derivative and radiation-sensitive resin composition SRSF1, ARL1, ERCC4 GAA 1889/4885MEN1 3535/4885ALOX15 966/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.